Key drugs reduce fracture risk in osteoporosis
1. This systematic review demonstrated that in postmenopausal women with osteoporosis, bisphosphonates, denosumab and teriparatide were associated with a significantly ...
1. This systematic review demonstrated that in postmenopausal women with osteoporosis, bisphosphonates, denosumab and teriparatide were associated with a significantly ...
1. Scaffolds coated with a polyelectrolyte multilayer (PEM) film released growth factors (GFs) with individual temporal control during bone reconstruction. ...
Image: PD 1. Romosozumab, an anti-sclerostin antibody, significantly increased bone mineral density in postmenopausal women compared to placebo. 2. When ...
Image: PD/Tau Protein Alzheimer Disease In this section, we will highlight the key high-impact studies, updates, and analyses published in ...
Image: PD 1. Pathogenic variants of the plastin 3 (PLS3) gene were identified in five families with X-linked osteoporosis and ...
Image: PD 1. Repeat bone mineral density (BMD) scans did not meaningfully change risk stratification for major osteoporotic or hip ...
Image: PD 1. The combination of teriparatide and enosumab increased bone mineral density in postmenopausal women with osteoporosis more than ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.